Recombinant IFN-β for Postseptic Acute Lung Injury-What's the Mechanism?

Am J Respir Cell Mol Biol. 2018 Jul;59(1):1-2. doi: 10.1165/rcmb.2018-0054ED.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Acute Lung Injury / drug therapy
  • Acute Lung Injury / etiology*
  • Animals
  • Humans
  • Interferon-beta / administration & dosage
  • Interferon-beta / therapeutic use
  • Mice
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / therapeutic use
  • Risk Factors
  • Sepsis / complications*
  • Sepsis / drug therapy
  • Shock, Septic / drug therapy

Substances

  • Recombinant Proteins
  • Interferon-beta